Blood

Adult T-cell leukemia/lymphoma

ORPHA:86875 ↗

Search all Adult T-cell leukemia/lymphoma trialsAlert me when a trial opens

103

studies recruiting now

as of 7 Sept 2026

838

studies registered in total

as of 7 Sept 2026

countries with a recruiting site

as of 7 Sept 2026

20 Jan 2026

most recent study posted

among recruiting studies

Recruiting trials

RecruitingNot applicableNCT05621291

A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...

Sponsor National Cancer Institute (NCI)Where United States (8 sites)Studying NGS testingUpdated 4 Sept 2026

See details

RecruitingPhase 1NCT07350863

U69-CART-Cells For R/R T-ALL

Sponsor The First Affiliated Hospital of Soochow UniversityWhere China (1 site)Studying CXCR4 CCR9 CAR-TUpdated 2 Sept 2026

See details

RecruitingPhase 1NCT06408194

Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies

Sponsor Stanford UniversityWhere United States (1 site)Studying CD22CART infusion, TisagenlecleucelUpdated 1 Sept 2026

See details

RecruitingNCT01676805

Tissue Collection for Studies of Lymph Cancer

Sponsor National Cancer Institute (NCI)Where United States, Jamaica (2 sites)Updated 1 Sept 2026

See details

RecruitingNCT02682667

Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols

Sponsor National Cancer Institute (NCI)Where United States (1 site)Updated 1 Sept 2026

See details

Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.

See all 103 recruiting studies

Where recruiting studies are running

Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.

China Jamaica United States

Keep watching

Get an email when a new Adult T-cell leukemia/lymphoma study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

NORD ↗GARD ↗Orphanet ORPHA:86875 ↗

About Adult T-cell leukemia/lymphoma

RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.

Orphanet expert page ↗GARD (NIH) ↗

Treatments being studied

2 approved treatments and 6 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.

Approved: Mogamulizumab (Poteligeo)Approved: Valemetostat Tosylate

Phase 2Belinostat (Beleodaq)

Phase 2Interferon Alfa-2b (Intron a)

Phase 2Brentuximab Vedotin (Adcetris)

Phase 2Peginterferon Alfa-2b (Peg-intron)

Phase 2Lenalidomide (Lenalidomide accord)

Phase 2Zidovudine (Retrovir)

Related conditions

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).